Mepolizumab for treating severe eosinophilic asthma

Overview

Health Innovation Manchester, alongside expertise from secondary care partners and other community organisations in Greater Manchester, worked with local communities to identify, address and minimise healthcare inequalities. Our efforts were focussed on improving access to the latest health technologies, educational materials and medicines. We developed this project as part of the NHS England Innovation for Healthcare Inequalities Programme (InHIP), which aimed to improve access to NICE-approved technologies to address local healthcare needs using the Core20Plus5 approach.

We aimed to address local healthcare inequalities experienced by deprived and other under-served populations. Key stakeholders across NHS Greater Manchester (NHS GM), including Health Innovation Manchester, The Royal Oldham Hospital and the Treating Tobacco Dependency team identified that one of the greatest healthcare inequality challenges in Greater Manchester is paediatric asthma and the effects of second-hand smoke on asthma.